Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Active as of 2026-06-04 |
{
"resourceType" : "CodeSystem",
"id" : "condition-codes-cs",
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem condition-codes-cs</b></p><a name=\"condition-codes-cs\"> </a><a name=\"hccondition-codes-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">C50<a name=\"condition-codes-cs-C50\"> </a></td><td>C50 — Malignant neoplasm of breast</td></tr><tr><td style=\"white-space:nowrap\">C53<a name=\"condition-codes-cs-C53\"> </a></td><td>C53 — Malignant neoplasm of cervix uteri</td></tr><tr><td style=\"white-space:nowrap\">C54<a name=\"condition-codes-cs-C54\"> </a></td><td>C54 — Malignant neoplasm of corpus uteri</td></tr><tr><td style=\"white-space:nowrap\">C55<a name=\"condition-codes-cs-C55\"> </a></td><td>C55 — Malignant neoplasm of uterus, part unspecified</td></tr><tr><td style=\"white-space:nowrap\">C56<a name=\"condition-codes-cs-C56\"> </a></td><td>C56 — Malignant neoplasm of ovary</td></tr><tr><td style=\"white-space:nowrap\">C61<a name=\"condition-codes-cs-C61\"> </a></td><td>C61 — Malignant neoplasm of prostate</td></tr><tr><td style=\"white-space:nowrap\">C18<a name=\"condition-codes-cs-C18\"> </a></td><td>C18 — Malignant neoplasm of colon</td></tr><tr><td style=\"white-space:nowrap\">C19<a name=\"condition-codes-cs-C19\"> </a></td><td>C19 — Malignant neoplasm of rectosigmoid junction</td></tr><tr><td style=\"white-space:nowrap\">C20<a name=\"condition-codes-cs-C20\"> </a></td><td>C20 — Malignant neoplasm of rectum</td></tr><tr><td style=\"white-space:nowrap\">C15<a name=\"condition-codes-cs-C15\"> </a></td><td>C15 — Malignant neoplasm of oesophagus</td></tr><tr><td style=\"white-space:nowrap\">C16<a name=\"condition-codes-cs-C16\"> </a></td><td>C16 — Malignant neoplasm of stomach</td></tr><tr><td style=\"white-space:nowrap\">C22<a name=\"condition-codes-cs-C22\"> </a></td><td>C22 — Malignant neoplasm of liver and intrahepatic bile ducts</td></tr><tr><td style=\"white-space:nowrap\">C25<a name=\"condition-codes-cs-C25\"> </a></td><td>C25 — Malignant neoplasm of pancreas</td></tr><tr><td style=\"white-space:nowrap\">C34<a name=\"condition-codes-cs-C34\"> </a></td><td>C34 — Malignant neoplasm of bronchus and lung</td></tr><tr><td style=\"white-space:nowrap\">C32<a name=\"condition-codes-cs-C32\"> </a></td><td>C32 — Malignant neoplasm of larynx</td></tr><tr><td style=\"white-space:nowrap\">C11<a name=\"condition-codes-cs-C11\"> </a></td><td>C11 — Malignant neoplasm of nasopharynx</td></tr><tr><td style=\"white-space:nowrap\">C73<a name=\"condition-codes-cs-C73\"> </a></td><td>C73 — Malignant neoplasm of thyroid gland</td></tr><tr><td style=\"white-space:nowrap\">C64<a name=\"condition-codes-cs-C64\"> </a></td><td>C64 — Malignant neoplasm of kidney, except renal pelvis</td></tr><tr><td style=\"white-space:nowrap\">C67<a name=\"condition-codes-cs-C67\"> </a></td><td>C67 — Malignant neoplasm of bladder</td></tr><tr><td style=\"white-space:nowrap\">C43<a name=\"condition-codes-cs-C43\"> </a></td><td>C43 — Malignant melanoma of skin</td></tr><tr><td style=\"white-space:nowrap\">C71<a name=\"condition-codes-cs-C71\"> </a></td><td>C71 — Malignant neoplasm of brain</td></tr><tr><td style=\"white-space:nowrap\">C40<a name=\"condition-codes-cs-C40\"> </a></td><td>C40 — Malignant neoplasm of bone and articular cartilage of limbs</td></tr><tr><td style=\"white-space:nowrap\">C49<a name=\"condition-codes-cs-C49\"> </a></td><td>C49 — Malignant neoplasm of connective and soft tissue</td></tr><tr><td style=\"white-space:nowrap\">C81<a name=\"condition-codes-cs-C81\"> </a></td><td>C81 — Hodgkin lymphoma</td></tr><tr><td style=\"white-space:nowrap\">C83<a name=\"condition-codes-cs-C83\"> </a></td><td>C83 — Non-follicular lymphoma (incl. Burkitt)</td></tr><tr><td style=\"white-space:nowrap\">C85<a name=\"condition-codes-cs-C85\"> </a></td><td>C85 — Other and unspecified types of non-Hodgkin lymphoma</td></tr><tr><td style=\"white-space:nowrap\">C90<a name=\"condition-codes-cs-C90\"> </a></td><td>C90 — Multiple myeloma and malignant plasma cell neoplasms</td></tr><tr><td style=\"white-space:nowrap\">C91<a name=\"condition-codes-cs-C91\"> </a></td><td>C91 — Lymphoid leukaemia</td></tr><tr><td style=\"white-space:nowrap\">C92<a name=\"condition-codes-cs-C92\"> </a></td><td>C92 — Myeloid leukaemia</td></tr><tr><td style=\"white-space:nowrap\">C46<a name=\"condition-codes-cs-C46\"> </a></td><td>C46 — Kaposi sarcoma</td></tr><tr><td style=\"white-space:nowrap\">C69<a name=\"condition-codes-cs-C69\"> </a></td><td>C69 — Malignant neoplasm of eye and adnexa (incl. retinoblastoma)</td></tr><tr><td style=\"white-space:nowrap\">D05<a name=\"condition-codes-cs-D05\"> </a></td><td>D05 — Carcinoma in situ of breast</td></tr><tr><td style=\"white-space:nowrap\">D06<a name=\"condition-codes-cs-D06\"> </a></td><td>D06 — Carcinoma in situ of cervix uteri</td></tr></table></div>"
},
"url" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/condition-codes-cs",
"version" : "0.1.0",
"name" : "ConditionCodesCS",
"title" : "Kenya Oncology Condition (ICD-10) Code System",
"status" : "active",
"experimental" : false,
"date" : "2026-06-04T14:49:30+00:00",
"publisher" : "Digital Health Agency (DHA), Kenya",
"contact" : [
{
"name" : "Digital Health Agency (DHA), Kenya",
"telecom" : [
{
"system" : "url",
"value" : "https://dha.go.ke"
},
{
"system" : "email",
"value" : "info@dha.go.ke"
}
]
},
{
"name" : "Digital Health Agency Kenya – FHIR Team",
"telecom" : [
{
"system" : "email",
"value" : "info@dha.go.ke",
"use" : "work"
},
{
"system" : "url",
"value" : "https://dha.go.ke",
"use" : "work"
}
]
}
],
"description" : "ICD-10 diagnosis codes for the most common malignancies in Kenya.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "KE",
"display" : "Kenya"
}
]
}
],
"caseSensitive" : true,
"content" : "complete",
"count" : 33,
"concept" : [
{
"code" : "C50",
"display" : "C50 — Malignant neoplasm of breast"
},
{
"code" : "C53",
"display" : "C53 — Malignant neoplasm of cervix uteri"
},
{
"code" : "C54",
"display" : "C54 — Malignant neoplasm of corpus uteri"
},
{
"code" : "C55",
"display" : "C55 — Malignant neoplasm of uterus, part unspecified"
},
{
"code" : "C56",
"display" : "C56 — Malignant neoplasm of ovary"
},
{
"code" : "C61",
"display" : "C61 — Malignant neoplasm of prostate"
},
{
"code" : "C18",
"display" : "C18 — Malignant neoplasm of colon"
},
{
"code" : "C19",
"display" : "C19 — Malignant neoplasm of rectosigmoid junction"
},
{
"code" : "C20",
"display" : "C20 — Malignant neoplasm of rectum"
},
{
"code" : "C15",
"display" : "C15 — Malignant neoplasm of oesophagus"
},
{
"code" : "C16",
"display" : "C16 — Malignant neoplasm of stomach"
},
{
"code" : "C22",
"display" : "C22 — Malignant neoplasm of liver and intrahepatic bile ducts"
},
{
"code" : "C25",
"display" : "C25 — Malignant neoplasm of pancreas"
},
{
"code" : "C34",
"display" : "C34 — Malignant neoplasm of bronchus and lung"
},
{
"code" : "C32",
"display" : "C32 — Malignant neoplasm of larynx"
},
{
"code" : "C11",
"display" : "C11 — Malignant neoplasm of nasopharynx"
},
{
"code" : "C73",
"display" : "C73 — Malignant neoplasm of thyroid gland"
},
{
"code" : "C64",
"display" : "C64 — Malignant neoplasm of kidney, except renal pelvis"
},
{
"code" : "C67",
"display" : "C67 — Malignant neoplasm of bladder"
},
{
"code" : "C43",
"display" : "C43 — Malignant melanoma of skin"
},
{
"code" : "C71",
"display" : "C71 — Malignant neoplasm of brain"
},
{
"code" : "C40",
"display" : "C40 — Malignant neoplasm of bone and articular cartilage of limbs"
},
{
"code" : "C49",
"display" : "C49 — Malignant neoplasm of connective and soft tissue"
},
{
"code" : "C81",
"display" : "C81 — Hodgkin lymphoma"
},
{
"code" : "C83",
"display" : "C83 — Non-follicular lymphoma (incl. Burkitt)"
},
{
"code" : "C85",
"display" : "C85 — Other and unspecified types of non-Hodgkin lymphoma"
},
{
"code" : "C90",
"display" : "C90 — Multiple myeloma and malignant plasma cell neoplasms"
},
{
"code" : "C91",
"display" : "C91 — Lymphoid leukaemia"
},
{
"code" : "C92",
"display" : "C92 — Myeloid leukaemia"
},
{
"code" : "C46",
"display" : "C46 — Kaposi sarcoma"
},
{
"code" : "C69",
"display" : "C69 — Malignant neoplasm of eye and adnexa (incl. retinoblastoma)"
},
{
"code" : "D05",
"display" : "D05 — Carcinoma in situ of breast"
},
{
"code" : "D06",
"display" : "D06 — Carcinoma in situ of cervix uteri"
}
]
}